The Schedule of Pharmaceutical Benefits was updated on 1 May 2024. New, Amended and Deleted items can be found on the Summary of Changes page.

The following updates have also been made to the PBS Website on the dates specified.

• Section 19A medicines subsidised by the Pharmaceutical Benefits Scheme - 1 May 2024
• Ex-manufacturer price - 1 May 2024
• Formulary Allocations - 1 May 2024
• Drugs subject to Price Disclosure - 1 May 2024
• Medicine Status Website - 1 May 2024
• Recommendations made by the Pharmaceutical Benefits Advisory Committee (PBAC) – March 2024 - 26 April 2024
• Publication of Stage 1 and Stage 2 PBS Process Improvements metrics report for 2022-23 - 19 April 2024
• Economics Sub Committee (ESC) - 19 April 2024
• Drug Utilisation Sub Committee (DUSC) - 19 April 2024
• Section 100 – Highly Specialised Drugs Program - 17 April 2024
• PBS and RPBS Section 85 Date of Supply Data - 16 April 2024
• Updates to the HTA Policy and Methods Review Reference Committee – 15 April 2024
• PBAC Public Summary Documents – December 2023 meeting - 5 April 2024
• Agenda for the July 2024 PBAC meeting – 3 April 2024
• National Health (Pharmaceutical Benefits) Regulations 2017 amendments - 3 April 2024
• Public Consultation: Draft 2024-25 Cost Recovery Implementation Statement (CRIS) for listing medicines on the PBS and designated vaccines on the NIP - 2 April 2024